𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma : A North Central Cancer Treatment Group Phase II Trial

✍ Scribed by Steven R. Alberts; Hani Al-Khatib; Michelle R. Mahoney; Lawerence Burgart; Peter J. Cera; Patrick J. Flynn; Tom R. Finch; Ralph Levitt; Harold E. Windschitl; James A. Knost; Loren K. Tschetter

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
97 KB
Volume
103
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase III trial of 5-fluorouracil and
A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. A mayo clinic/north central cancer treatment group study
✍ Michael J. O'Connell πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 498 KB πŸ‘ 2 views

The Mayo Clinic and the North Central Cancer Treatment Group (NCCTG) conducted a randomized clinical trial comparing five different combination chemotherapeutic regimens to single-agent 5-fluorouracil (5-FU), given by intravenous bolus technique (500 mg/m2 for 5 days) as a control, in the treatment

A phase II trial of 5-fluorouracil, leuc
A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma
✍ Pedro M. Sanz-Altamira; Karen Ferrante; Roger L. Jenkins; W. David Lewis; Mark S πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 65 KB πŸ‘ 2 views

## Background: Unresectable adenocarcinoma of the biliary tree are associated with a very poor prognosis. 5-fluorouracil (5-fu) combination regimens have produced objective response rates in approximately 10-20% of patients. leucovorin increases the selective cytotoxicity of 5-fu. there also are en

A phase II trial of 5-fluorouracil, doxo
A phase II trial of 5-fluorouracil, doxorubicin, mitomycin C, and leucovorin in advanced gastric carcinoma
✍ Susan G. Arbuck; Yusuf Silk Md; Harold O. Douglass Jr.; Hector Nava; Youcef M. R πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 363 KB πŸ‘ 2 views

To determine the feasibility and toxicity of combining leucovorin (CF) with a 5fluorouracil(5-FU) combination chemotherapy regimen currently accepted by many as standard treatment for gastric cancer, CF (500 mg/m') was administered in combination with the Georgetown S-FU, doxorubicin, and mitomycin

A phase II trial of methotrexate, cispla
A phase II trial of methotrexate, cisplatin, 5-fluorouracil, and leucovorin in the treatment of invasive and metastatic urothelial carcinoma
✍ William K. Oh; Judith Manola; Jerome P. Richie; Kevin R. Loughlin; Philip W. Kan πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 78 KB πŸ‘ 2 views

The current treatment of advanced urothelial carcinoma generates high response rates but is associated with poor overall survival. The current study evaluated the efficacy and toxicity of a new combination of active drugs in the treatment of urothelial carcinoma. ## METHODS. Twenty-four patients